Log In
Print
BCIQ
Print
Print this Print this
 

ARG201

  Manage Alerts
Collapse Summary General Information
Company arGentis Pharmaceuticals LLC
DescriptionSolubilized type I native bovine collagen
Molecular Target Collagen
Mechanism of ActionImmune modulation
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase II
Standard IndicationScleroderma
Indication DetailsTreat diffuse cutaneous systemic sclerosis; Treat systemic scleroderma
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today